Stem definition | Drug id | CAS RN |
---|---|---|
4289 | 6217-54-5 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pneumonia aspiration | 198.88 | 43.50 | 61 | 1395 | 30943 | 50572725 |
Coma | 162.58 | 43.50 | 61 | 1395 | 56818 | 50546850 |
Gastrooesophageal reflux disease | 145.10 | 43.50 | 61 | 1395 | 76367 | 50527301 |
Somnolence | 112.19 | 43.50 | 64 | 1392 | 154921 | 50448747 |
Muscle spasticity | 65.99 | 43.50 | 23 | 1433 | 17161 | 50586507 |
Respiratory disorder | 62.64 | 43.50 | 26 | 1430 | 31161 | 50572507 |
Body temperature increased | 55.84 | 43.50 | 24 | 1432 | 31317 | 50572351 |
Ear pain | 54.84 | 43.50 | 23 | 1433 | 28260 | 50575408 |
Night sweats | 51.05 | 43.50 | 23 | 1433 | 33551 | 50570117 |
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pneumonia aspiration | 108.44 | 43.39 | 42 | 1287 | 59229 | 64438174 |
Gastrooesophageal reflux disease | 94.70 | 43.39 | 42 | 1287 | 83101 | 64414302 |
Coma | 92.59 | 43.39 | 42 | 1287 | 87573 | 64409830 |
Somnolence | 69.01 | 43.39 | 46 | 1283 | 203599 | 64293804 |
Child abuse | 59.38 | 43.39 | 9 | 1320 | 211 | 64497192 |
Muscle spasticity | 53.72 | 43.39 | 18 | 1311 | 16651 | 64480752 |
Victim of child abuse | 53.29 | 43.39 | 10 | 1319 | 861 | 64496542 |
Epidural lipomatosis | 46.95 | 43.39 | 9 | 1320 | 868 | 64496535 |
Ear pain | 46.50 | 43.39 | 18 | 1311 | 25118 | 64472285 |
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:35610 | antineoplastic agents |
CHEBI has role | CHEBI:50733 | Dietary Supplement |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
CHEBI has role | CHEBI:83146 | Daphnia tenebrosa metabolites |
CHEBI has role | CHEBI:84735 | algal metabolites |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Pregnancy, function | indication | 289908002 | |
Breastfeeding (mother) | indication | 413712001 | |
Prevention of Fetal Neural Tube Defects during Pregnancy | off-label use |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.37 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Aromatase | Enzyme | IC50 | 4.48 | CHEMBL | |||||
Retinoic acid receptor RXR-alpha | Nuclear hormone receptor | Ki | 5.20 | CHEMBL | |||||
Free fatty acid receptor 1 | GPCR | AGONIST | EC50 | 6 | IUPHAR | ||||
Oxoeicosanoid receptor 1 | GPCR | IC50 | 5.70 | CHEMBL | |||||
Prostaglandin G/H synthase 2 | Enzyme | IC50 | 5.01 | CHEMBL | |||||
Prostaglandin G/H synthase 1 | Enzyme | IC50 | 4.82 | CHEMBL | |||||
Transient receptor potential cation channel subfamily A member 1 | Ion channel | ACTIVATOR | EC50 | 4.40 | IUPHAR |
ID | Source |
---|---|
4020132 | VUID |
N0000148111 | NUI |
4020132 | VANDF |
C2348308 | UMLSCUI |
CHEBI:28125 | CHEBI |
F22 | PDB_CHEM_ID |
HXA | PDB_CHEM_ID |
CHEMBL367149 | ChEMBL_ID |
DB03756 | DRUGBANK_ID |
C532150 | MESH_SUPPLEMENTAL_RECORD_UI |
1051 | IUPHAR_LIGAND_ID |
6428 | INN_ID |
ZAD9OKH9JC | UNII |
445580 | PUBCHEM_CID |
1006469 | RXNORM |
002051 | NDDF |
226368001 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
CitraNatal Harmony 3.0 | HUMAN PRESCRIPTION DRUG LABEL | 8 | 0178-0796 | CAPSULE, GELATIN COATED | 260 mg | ORAL | unapproved drug other | 10 sections |
CitraNatal Harmony | HUMAN PRESCRIPTION DRUG LABEL | 8 | 0178-0798 | CAPSULE, GELATIN COATED | 260 mg | ORAL | UNAPPROVED DRUG OTHER | 11 sections |
CitraNatal Harmony | HUMAN PRESCRIPTION DRUG LABEL | 8 | 0178-0799 | CAPSULE, GELATIN COATED | 250 mg | ORAL | Unapproved drug other | 11 sections |
CitraNatal Harmony | HUMAN PRESCRIPTION DRUG LABEL | 8 | 0178-0812 | CAPSULE, GELATIN COATED | 250 mg | ORAL | Unapproved drug other | 11 sections |
CitraNatal Medley | HUMAN PRESCRIPTION DRUG LABEL | 8 | 0178-0896 | CAPSULE, GELATIN COATED | 200 mg | ORAL | unapproved drug other | 10 sections |
Vitafol Ultra | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-0093 | CAPSULE, LIQUID FILLED | 200 mg | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
Vitafol Fe Plus | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-7473 | CAPSULE, LIQUID FILLED | 200 mg | ORAL | UNAPPROVED DRUG OTHER | 14 sections |
TriStart DHA | HUMAN PRESCRIPTION DRUG LABEL | 15 | 15370-250 | CAPSULE, LIQUID FILLED | 200 mg | ORAL | UNAPPROVED DRUG OTHER | 12 sections |
PNV-DHA | HUMAN PRESCRIPTION DRUG LABEL | 10 | 42192-321 | CAPSULE, GELATIN COATED | 300 mg | ORAL | unapproved drug other | 11 sections |
PNV-DHA | HUMAN PRESCRIPTION DRUG LABEL | 8 | 42192-323 | CAPSULE, GELATIN COATED | 300 mg | ORAL | unapproved drug other | 11 sections |
PNV-Omega | HUMAN PRESCRIPTION DRUG LABEL | 13 | 42192-332 | CAPSULE, GELATIN COATED | 300 mg | ORAL | unapproved drug other | 12 sections |
Prenaissance | HUMAN PRESCRIPTION DRUG LABEL | 9 | 42192-341 | CAPSULE, LIQUID FILLED | 325 mg | ORAL | UNAPPROVED DRUG OTHER | 10 sections |
Prenaissance Plus | HUMAN PRESCRIPTION DRUG LABEL | 8 | 42192-343 | CAPSULE, LIQUID FILLED | 250 mg | ORAL | UNAPPROVED DRUG OTHER | 10 sections |
Animi-3 with Vitamin D | HUMAN PRESCRIPTION DRUG LABEL | 8 | 66213-542 | CAPSULE | 250 mg | ORAL | unapproved drug other | 14 sections |
Animi-3 | HUMAN PRESCRIPTION DRUG LABEL | 8 | 66213-543 | CAPSULE | 250 mg | ORAL | unapproved drug other | 14 sections |
TRICARE PRENATAL DHA ONE | HUMAN PRESCRIPTION DRUG LABEL | 17 | 67112-401 | CAPSULE, GELATIN COATED | 215 mg | ORAL | unapproved drug other | 12 sections |
PRENATE Restore | HUMAN PRESCRIPTION DRUG LABEL | 12 | 75854-308 | CAPSULE, GELATIN COATED | 400 mg | ORAL | unapproved drug other | 13 sections |
PRENATE Enhance | HUMAN PRESCRIPTION DRUG LABEL | 12 | 75854-309 | CAPSULE, GELATIN COATED | 400 mg | ORAL | unapproved drug other | 13 sections |
PRENATE DHA | HUMAN PRESCRIPTION DRUG LABEL | 10 | 75854-312 | CAPSULE, GELATIN COATED | 300 mg | ORAL | unapproved drug other | 13 sections |
Prenate Essential | HUMAN PRESCRIPTION DRUG LABEL | 14 | 75854-313 | CAPSULE, GELATIN COATED | 300 mg | ORAL | unapproved drug other | 13 sections |
Prenate Mini | HUMAN PRESCRIPTION DRUG LABEL | 15 | 75854-315 | CAPSULE, GELATIN COATED | 350 mg | ORAL | unapproved drug other | 12 sections |